Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.56M Sell
84,359
-5,333
-6% -$159K 0.03% 420
2026
Q1
$2.41M Sell
89,692
-1,856
-2% -$60.1K 0.03% 400
2025
Q4
$3.5M Buy
91,548
+18,897
+26% +$699K 0.05% 362
2025
Q3
$2.94M Sell
72,651
-345
-0.5% -$11K 0.04% 368
2025
Q2
$2.12M Buy
72,996
+6,924
+10% +$185K 0.03% 425
2025
Q1
$1.61M Buy
66,072
+11,661
+21% +$280K 0.02% 461
2024
Q4
$1.17M Buy
+54,411
New +$1.07M 0.02% 495

Other funds holding IBEX

Segall Bryant & Hamill's IBEX Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its IBEX (IBEX) stake by 5.9% in Q2 2026, selling an estimated $159K and leaving 84,359 shares worth $2.56M. The position accounts for 0.03% of the portfolio, ranked #420.

Segall Bryant & Hamill first reported a position in IBEX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.5M in Q4 2025. 153 funds tracked by Wall St. Rank hold IBEX as of Q2 2026.

  • Segall Bryant & Hamill held 84,359 shares of IBEX worth $2.56M as of Q2 2026.
  • Segall Bryant & Hamill sold 5,333 IBEX shares in Q2 2026, an estimated $159K.
  • IBEX made up 0.03% of Segall Bryant & Hamill's portfolio in Q2 2026, its #420 holding.
  • Segall Bryant & Hamill first reported a position in IBEX in Q4 2024 and has held it in 7 quarters since.
  • Segall Bryant & Hamill's IBEX position peaked at $3.5M in Q4 2025.
  • 153 funds tracked by Wall St. Rank held IBEX as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.